How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/superficial-basal-cell-carcinoma.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Superficial basal cell carcinoma — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Superficial basal cell carcinoma (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Superficial basal cell carcinoma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Aldara	IMIQUIMOD	Bausch Health	imiquimod	7,8-dihydro-8-oxoguanine triphosphatase	1997-01-01
Carac	5-fu	Spectrum Pharms	Nucleoside Metabolic Inhibitor	Aromatase	1962-01-01
Carac	fluorouracil	Extrovis	Nucleoside Metabolic Inhibitor [EPC]	Aromatase	1962-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Bausch Health · 1 drug in Superficial basal cell carcinoma
Extrovis · 1 drug in Superficial basal cell carcinoma
Spectrum Pharms · 1 drug in Superficial basal cell carcinoma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Superficial basal cell carcinoma:

Cite this brief

Drug Landscape (2026). Superficial basal cell carcinoma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/superficial-basal-cell-carcinoma. Accessed 2026-06-10.

Superficial basal cell carcinoma full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing